Highest-materiality recent filing
Wyndham CEO Ballotti diagnosed with multiple myeloma; CAO Rossi to depart, Androski to succeed
CEO Geoff Ballotti diagnosed with multiple myeloma (treatable bone cancer); prognosis favorable, treatment at Dana-Farber; he plans to continue working largely as normal with reduced travel.
Wyndham Q1 adjusted EPS up 12% to $0.96; rooms up 4%, pipeline record 2,200 hotels
Net income flat at $61M; adjusted net income +9% to $73M; diluted EPS $0.80 (+3%); adjusted diluted EPS $0.96 (+12%).
Wyndham issues $650M 5.625% senior notes due 2033 to repay credit facility debt
Issued $650M aggregate principal of 5.625% senior notes due March 1, 2033; interest paid semi-annually.
Wyndham Hotels Reports Q4 & Full-Year 2025 Results, Increases Dividend 5%, Provides 2026 Outlook
Full-year 2025 adjusted diluted EPS rose 6% to $4.58, adjusted EBITDA grew 3% to $718M, in line with expectations.
Wyndham Hotels CFO Michele Allen departs; Kurt Albert named Interim CFO
Michele Allen steps down as CFO and Head of Strategy effective Nov 4, 2025, to pursue external opportunity.
Wyndham Q3 adj EPS up 5% but fee revenue down 3%; lowers FY25 guidance
Q3 net income $105M (+3% YoY); adj diluted EPS $1.46 (+5% YoY); fee-related revenue $382M (-3% YoY).
Wyndham Q2 adjusted EPS $1.33 beats, raises FY2025 EPS outlook, pipeline record 255k rooms
Q2 2025 adjusted diluted EPS $1.33 (+18% YoY or +11% comparable basis); GAAP diluted EPS $1.13 (+6%).
Wyndham Hotels Q1 adj. EPS up 20% comparable but cuts FY RevPAR guidance to (2%)-1%
Q1 diluted EPS $0.78 vs $0.19 YoY; adjusted EPS $0.86, up 10% reported (20% comparable).
Wyndham Q4 EPS $1.08 (+80%), RevPAR +5%; raises dividend 8%, guides FY25
Q4 diluted EPS $1.08 (+80%), adjusted EPS $1.04 (+14%); full-year adj. EBITDA $694M (+5%).
Wyndham Q3 adjusted EPS $1.39, up 6% YoY; raises FY 2024 EPS outlook
Diluted EPS $1.29 (+7%); adjusted diluted EPS $1.39 (+6%), fee revenue $394M.
Wyndham Q2 adjusted EPS $1.13 beats prior year; raises FY EPS guidance to $4.20-4.32
Net income $86M (+23% YoY); diluted EPS $1.07 (+30% YoY); adjusted diluted EPS $1.13 (+22% YoY).
Wyndham Hotels Q1 adjusted EPS $0.78; raises FY2024 EPS outlook; pipeline record 243k rooms
Q1 global RevPAR +1% constant currency; US RevPAR -5%, International +14%.
Wyndham Hotels says Choice's hostile offer undervalues company; urges vote for its nominees
Board calls Choice's offer inadequate: insufficient valuation, unattractive consideration mix, and asymmetrical regulatory risk.
Wyndham Q4 adjusted EPS $0.91 vs $0.72 YoY; record room openings, dividend raised 9%
Q4 diluted EPS $0.60, net income $50M; adjusted diluted EPS $0.91, adjusted net income $75M, adjusted EBITDA $154M (+22% YoY).
Wyndham confirms unsolicited exchange offer from Choice at ~$86/share
Choice Hotels commenced unsolicited exchange offer to acquire all Wyndham shares at ~$86 per share.
Choice's revised offer valued at $86/share (down from $90); Wyndham board unanimously rejects it.
Wyndham Q3: $103M net income, RevPAR +3%; rejects Choice; raises FY EPS outlook
Net income $103M ($1.21 diluted EPS); adjusted EBITDA $200M (+5% YoY).
Wyndham Q2 global RevPAR up 7%; pipeline grows 10%; board adds $400M buyback
Global RevPAR grew 7% YoY constant currency; U.S. down 1% but international up 34%.
Wyndham closes $1.14B term loan refinancing, extends maturity to 2030
New $1.144B Senior Secured Term Loan B matures May 2030, replacing Term Loan B due 2025.
Wyndham Q1 global RevPAR +12%, raises FY adjusted EBITDA outlook to $654-664M
Global RevPAR grew 12% YoY in constant currency; U.S. RevPAR up 4%.
Wyndham Q4 adj EPS $0.72 beats; RevPAR +15%; dividend +9%; FY23 EBITDA guide $650-660M
Q4 adj diluted EPS $0.72 vs $0.52 YoY; net income $56M.
Wyndham Hotels Q3 2022: Adj EPS $1.21, RevPAR up 12%, raises FY22 outlook, adds $400M buyback
Diluted EPS $1.13 GAAP ($1.21 adjusted); net income $101M; adjusted EBITDA $191M.
Wyndham Hotels President of Americas Scott LePage resigns effective Oct 14
Scott LePage, President, the Americas, resigned effective October 14, 2022.
Wyndham Q2 adjusted EPS $1.07 beats; raises FY EBITDA/EPS guidance; pipeline record 208k rooms
Q2 adjusted diluted EPS $1.07 vs $1.00 GAAP; net income $92M, adjusted net income $99M.
Net income $106M ($1.14 diluted EPS); adjusted EPS $0.95 vs $0.36 in Q1 2021.
Wyndham Hotels Q4 net income $48M; U.S. RevPAR exceeds 2019; Board adds $400M buyback
Q4 2021 adjusted diluted EPS $0.69; full-year adjusted EPS $3.16; adjusted EBITDA $590M.
CorePoint Lodging will pay Wyndham approx $84M termination fees upon closing of CPLG's merger, targeted Q1 2022.
Wyndham Hotels Q3 net income $103M, beats; raises dividend 33% to $0.32/share
Diluted EPS $1.09 ($1.16 adj) vs $0.29 ($0.36 adj) in Q3 2020; net income $103M vs $27M.
Wyndham Q2 adj.EPS $0.95 beats; dividend raised 50% to $0.24; FY outlook $525-535M EBITDA
Q2 adj. diluted EPS $0.95 vs $0.10 YoY; net income $68M vs loss $174M.
On July 31, 2026 (the “Effective Date”), Nicola Rossi, Chief Accounting Officer of Wyndham Hotels & Resorts, Inc. (the “Company”), will depart from the Company.
As of the Effective Date, Christopher Androski, age 52, who is currently the Company’s Senior Vice President and Controller, will assume the role of Chief Accounting Officer.
On September 16, 2022, Scott LePage, President, the Americas, of Wyndham Hotels & Resorts, Inc. (the “Company”) notified the Company of his decision to resign from the Company, effective October 14, 2022, and pursue an opportunity outside of the hospitality industry.
Max materiality 0.90 · Median 0.70 · Most common event earnings